^
BIOMARKER:
CDKN2A mutation
i
Other names: CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A
Entrez ID:
Related biomarkers:
CDKN2A mutation
Triple Negative Breast Cancer
atezolizumab
Sensitive
:
B
CDKN2A mutation
Breast Cancer
ribociclib
Resistant
:
B
CDKN2A mutation
Gallbladder Cancer
palbociclib
Resistant
:
C3
CDKN2A mutation
Clear Cell Renal Cell Carcinoma
palbociclib
Sensitive
:
C3
CDKN2A mutation
Pancreatic Cancer
palbociclib
Resistant
:
C3
CDKN2A mutation
Solid Tumor
Immunotherapy
Resistant
:
C3
CDKN2A mutation
Melanoma
Immunotherapy
Resistant
:
C3
CDKN2A mutation
Urothelial Cancer
Immunotherapy
Resistant
:
C3
CDKN2A mutation
SCCHN
AZD1775 + VIC-1911
Sensitive
:
D
CDKN2A mutation
NSCLC
AZD1775 + VIC-1911
Sensitive
:
D
CDKN2A mutation
Melanoma
palbociclib
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our